Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Verified Market Research | PRODUCT CODE: 1630127

Cover Image

PUBLISHER: Verified Market Research | PRODUCT CODE: 1630127

Global Vaginal Laxity Market Size By Treatment, By Competitive Landscape, By Geographic Scope And Forecast

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF & Excel (5 User License)
USD 4850
PDF & Excel (Enterprise User License)
USD 7550

Add to Cart

Vaginal Laxity Market Size And Forecast

Vaginal Laxity Market size was valued at USD 2.2 Billion in 2024 and is projected to reach USD 3.5 Billion by 2031, growing at a CAGR of 12% from 2024 to 2031.

Growing multiple vaginal childbirths, poor vaginal repairs from deliveries, prolonged sexual activity, history of multiple partners, trauma, and genetics are the factors growing the Vaginal Laxity Market. Additionally, a drop in estrogen levels caused by menopause and decreased estrogen production caused by health issues also fuel the Vaginal Laxity Market. The Global Vaginal Laxity Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.

Global Vaginal Laxity Market Definition

Vaginal laxity is a poorly investigated indication of pelvic floor dysfunction. It has been identified only recently as a sign of sexual dysfunction that is linked to pelvic organ prolapse (POP) and has been defined as a complaint of excessive vaginal looseness. It is most commonly experienced as reduced vaginal sensation during sexual intercourse, carrying physical and emotional consequences. For vaginal laxity, there is no objective, standardized diagnostic test. It has been defined in the literature as a self-reported symptom that can be elicited through interviews or questionnaires. Vaginal laxity (VL) is a symptom of vaginal looseness that may develop after pregnancy and vaginal delivery and may be affected by prior pelvic surgery, menopause, and aging.

Pelvic organ prolapse (POP) is a condition in which pelvic organs descend from the normal position. VL has attracted recent attention owing to the advent of energy-based treatments for this symptom. This symptom has been attracting recent attention to the advent of nonsurgical energy-based treatments and the new terminology by the International Urogynecological Association. The vaginal introitus was the most frequently cited location of laxity in an international survey of urogynecologists.

The decreased genito-pelvic sensation during sexual intercourse may be caused by vaginal laxity, which can harm the sexual quality of life. POP can be treated with surgery or with a pessary. Vaginal laxity can be treated surgically or in an office setting with energy-based (radiofrequency or laser) technologies that promote tissue remodeling. Vaginal laxity can be treated with a variety of treatments that help women regain their shape after childbirth. Kegel exercise, vaginal cones, tightening lotions, vagina rejuvenation, and reconstructive surgery are among the most popular treatments for vaginal laxity.

Global Vaginal Laxity Market Overview

Growing multiple vaginal childbirths, poor vaginal repairs from deliveries, prolonged sexual activity, history of multiple partners, trauma, and genetics are the factors growing the Vaginal Laxity Market. Many women suffer from vaginal laxity, which is a health and self-esteem issue that few like to discuss. The word refers to a vaginal "looseness." Because there is reduced vaginal sensation during intercourse, women with this condition typically lose sexual satisfaction. Some women lose confidence as a result, worrying that their sex life would negatively impact their relationships.

Both vaginal laxity and POP can affect sexual function. Additionally, a drop in estrogen levels caused by menopause and decreased estrogen production caused by health issues also fuel the Vaginal Laxity Market. The vaginal muscles become thinner and less elastic when estrogen levels drop, resulting in laxity as the vaginal canal and tissues around the vaginal opening lose strength and structure. Vaginal laxity is frequently accompanied by urinary incontinence and even digestive difficulties when muscles and tendons in the pelvic area weaken and offer less support to the vagina and other pelvic organs as women age.

Over the last few years, the Global Vaginal Laxity Market has shown increasing trends, and it is expected to increase at a significant rate between forecasted years. However, high cost of treatment and a lack of awareness among women along with this most women feel embarrassed to tell about vaginal health issues which restrains the market growth.

Global Vaginal Laxity Market Segmentation Analysis

The Global Vaginal Laxity Market is Segmented Based on Treatment And Geography.

Vaginal Laxity Market, By Treatment

  • Kegel Exercises
  • Vaginal Cones
  • Tightening Creams
  • Vagina Rejuvenation
  • Reconstructive Surgery

Based on Treatment, The market is classified into Kegel Exercises, Vaginal Cones, Tightening Creams, Vagina Rejuvenation, and Reconstructive Surgery. Kegel exercises can help strengthen the muscles that support the uterus, bladder, and bowel (large intestine). Vaginal rejuvenation is a broad term that refers to a variety of vaginal corrective treatments. Vaginal corrective treatments can be done for cosmetic reasons or to address age-related issues such vaginal laxity, loss of erotic sensation, labia majora tone loss, stress urinary incontinence, and lack of lubrication.

Vaginal Laxity Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on Geography, The Global Vaginal Laxity Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region segment is expected to grow at a significant rate during the forecasted years.

Key Players

The "Global Vaginal Laxity Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Alma Lasers, Lutronic, ThermiGen LLC., BTL Group of Companies, VenusConcept, Fotona, Viveve Medical Inc., Almirall, and Hologic Inc.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Product Code: 10352

TABLE OF CONTENTS

1. INTRODUCTION OF GLOBAL VAGINAL LAXITY MARKET

  • 1.1. Overview of the Market
  • 1.2. Scope of Report
  • 1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1. Data Mining
  • 3.2. Validation
  • 3.3. Primary Interviews
  • 3.4. List of Data Sources

4. GLOBAL VAGINAL LAXITY MARKET OUTLOOK

  • 4.1. Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
  • 4.3. Porters Five Force Model
  • 4.4. Value Chain Analysis

5. GLOBAL VAGINAL LAXITY MARKET, BY TREATMENT

  • 5.1. Overview
  • 5.2. Kegel Exercises
  • 5.3. Vaginal Cones
  • 5.4. Tightening Creams
  • 5.5. Vagina Rejuvenation
  • 5.6. Reconstructive Surgery

6. GLOBAL VAGINAL LAXITY MARKET, BY GEOGRAPHY

  • 6.1. Overview
  • 6.2. North America
    • 6.2.1. U.S.
    • 6.2.2. Canada
    • 6.2.3. Mexico
  • 6.3. Europe
    • 6.3.1. Germany
    • 6.3.2. U.K.
    • 6.3.3. France
    • 6.3.4. Rest of Europe
  • 6.4 Asia Pacific
    • 6.4.1 China
    • 6.4.2 Japan
    • 6.4.3 India
    • 6.4.4 Rest of Asia Pacific
  • 6.5 Rest of the World
    • 6.5.1 Latin America
    • 6.5.2 Middle East and Africa

7. GLOBAL VAGINAL LAXITY MARKET COMPETITIVE LANDSCAPE

  • 7.1. Overview
  • 7.2. Company Market Ranking
  • 7.3. Key Development Strategies

8. COMPANY PROFILES

  • 8.1. Alma Lasers
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 8.2. Lutronic
    • 8.2.1. Overview
    • 8.2.2. Financial Performance
    • 8.2.3. Product Outlook
    • 8.2.4. Key Developments
  • 8.3. ThermiGen LLC
    • 8.3.1. Overview
    • 8.3.2. Financial Performance
    • 8.3.3. Product Outlook
    • 8.3.4. Key Developments
  • 8.4. BTL Group of Companies
    • 8.4.1. Overview
    • 8.4.2. Financial Performance
    • 8.4.3. Product Outlook
    • 8.4.4. Key Developments
  • 8.5. VenusConcept
    • 8.5.1. Overview
    • 8.5.2. Financial Performance
    • 8.5.3. Product Outlook
    • 8.5.4. Key Developments
  • 8.6. Fotona
    • 8.6.1. Overview
    • 8.6.2. Financial Performance
    • 8.6.3. Product Outlook
    • 8.6.4. Key Developments
  • 8.7. Viveve Medical Inc.
    • 8.7.1. Overview
    • 8.7.2. Financial Performance
    • 8.7.3. Product Outlook
    • 8.7.4. Key Developments
  • 8.8. Almirall
    • 8.8.1. Overview
    • 8.8.2. Financial Performance
    • 8.8.3. Product Outlook
    • 8.8.4. Key Developments
  • 8.9. Hologic Inc.
    • 8.9.1. Overview
    • 8.9.2. Financial Performance
    • 8.9.3. Product Outlook
    • 8.9.4. Key Developments

9. Appendix

  • 9.1 Related Research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!